Page 1 | Search Results | Blood | American Society of Hematology

1-12 of 12

Sort by

Sort Order Select

Journal Articles

Reduced Calf Muscle Pump Function Is a Risk Factor for Venous Thromboembolism and Mortality

Damon E. Houghton, MDMS, Aneel A. Ashrani, MD MS, Ramila Mehta, MS, David O. Hodge, MS, David Liedl, RN, Thom Rooke, MD, Paul E. Wennberg, MD, Robert D. McBane, MD

Blood (2020) 136 (Supplement 1): 6–7.

https://doi.org/10.1182/blood-2020-139385

Published: 2020

Journal Articles

Incidental Pulmonary Embolism. Analysis of Mayo Clinic Venous Thromboembolism Database

Ewa Wysokinska, MD, Damon E. Houghton, MDMS, Danielle Vlazny, PA-C, Aneel A. Ashrani, MD MS, David A Froehling, MD, David O. Hodge, MS, Lisa Peterson, RN, Robert D. McBane, MD, Waldemar E. Wysokinski, MD PhD, Ana I Casanegra, MD

Blood (2019) 134 (Supplement_1): 1147.

https://doi.org/10.1182/blood-2019-131547

Published: 2019

Journal Articles

Treatment of Upper Extremity Deep Vein Thrombosis with Apixaban and Rivaroxaban

Damon E. Houghton, MDMS, Jordan Cochuyt, David O. Hodge, MS, Danielle Vlazny, PA-C, Ana I Casanegra, MD, Lisa Peterson, RN, David A Froehling, MD, Robert D. McBane, MD, Waldemar E. Wysokinski, MD PhD

Blood (2019) 134 (Supplement_1): 2158.

https://doi.org/10.1182/blood-2019-125099

Published: 2019

Journal Articles

Cancer-Associated Thrombosis and Bleeding Risk in Gastrointestinal Malignancies with Apixaban and Rivaroxaban Compared to Low Molecular Weight Heparin

Damon E. Houghton, MD, Dalene M. Bott-Kitslaar, APRN, CNP, Emily Vargas, MPH, David O. Hodge, MS, Teresa R Lang, PA-C, Lisa Peterson, RN, Ana I Casanegra, MD, Robert D. McBane, MD, Waldemar E. Wysokinski, MD PhD, David A Froehling, MD

Blood (2018) 132 (Supplement 1): 362.

https://doi.org/10.1182/blood-2018-99-114185

Published: 2018

Journal Articles

Utilization of Radiation Therapy in Multiple Myeloma: Trends and Changes in Practice

Sikander Ailawadhi, Ryan D. Frank, Zahara Meghji, Prachi Jani, MD, Raj Patel, MD, Mark A. Fiala, BS, Tanya S. Kakar, Sonikpreet Aulakh, MD, Ankita Aggarwal, David O. Hodge, MS, Taimur Sher, MD, Vivek Roy, MD, Meghna Ailawadhi, MD, Victoria R. Alegria, Prakash Vishnu, MD FACP, Aneel Paulus, MD, Asher A. Chanan-Khan, MD

Blood (2017) 130 (Supplement 1): 3395.

https://doi.org/10.1182/blood.V130.Suppl_1.3395.3395

Published: 2017

Journal Articles

Monoclonal Antibody Utilization Characteritics in Patients with Multiple Myeloma

Sikander Ailawadhi, Abdel-Ghani Azzouqa, Zahara Meghji, Tania Jain, MD, Nancy Diehl, Stephanie P. Gebhardt, Vishal Shah, David O. Hodge, MS, Raj Patel, MD, Prachi Jani, MD, Taimur Sher, MD, Vivek Roy, MD, Meghna Ailawadhi, MD, Victoria R. Alegria, Aneel Paulus, MD, Asher A. Chanan-Khan, MD, Rafael Fonseca, MD

Blood (2017) 130 (Supplement 1): 5440.

https://doi.org/10.1182/blood.V130.Suppl_1.5440.5440

Published: 2017

Journal Articles

Safety and Efficacy of Apixaban and Rivaroxaban for the Treatment of Upper Extremity Deep Vein Thrombosis

Damon E. Houghton, MD MSc, Dalene M. Bott-Kitslaar, APRN, CNP, Emily Vargas, MPH, David O. Hodge, MS, Teresa R. Ransone, PA-C, Ana Casanegra, MD, Lisa Peterson, RN, Robert D. McBane, MD, Waldemar E. Wysokinski, MD PhD

Blood (2017) 130 (Supplement 1): 2137.

https://doi.org/10.1182/blood.V130.Suppl_1.2137.2137

Published: 2017

Journal Articles

Utilization of Palliative Care Among Patients with Hematologic Malignancies: An Extensive National Analysis to Define Trends and Patterns

Sikander Ailawadhi, Ryan D. Frank, Nicolette T. Chimato, Prachi Jani, MD, Aaron C. Spaulding, Mark A. Fiala, BS, Judith Kaur, MD, David O. Hodge, MS, Taimur Sher, MD, Vivek Roy, MD, Prakash Vishnu, MD FACP, Meghna Ailawadhi, MD, Victoria R. Alegria, Aneel Paulus, MD, Asher A. Chanan-Khan, MD, Dorin T. Colibaseanu, MD

Blood (2017) 130 (Supplement 1): 2107.

https://doi.org/10.1182/blood.V130.Suppl_1.2107.2107

Published: 2017

Journal Articles

Survival Trends in Young Patients with Multiple Myeloma: Focus on Racial-Ethnic Minorities

Sikander Ailawadhi, Abdel-Ghani Azzouqa, MD, David O. Hodge, MS, Jordan Cochuyt, Zahara Meghji, Raj Patel, MD, Prachi Jani, MD, Tanya S. Kakar, Ankita Aggarwal, Taimur Sher, MD, Vivek Roy, MD, Meghna Ailawadhi, MD, Victoria R. Alegria, Aneel Paulus, MD, Asher A. Chanan-Khan, MD

Blood (2017) 130 (Supplement 1): 2149.

https://doi.org/10.1182/blood.V130.Suppl_1.2149.2149

Published: 2017

Journal Articles

Factors Determining Utilization of Stem Cell Transplant (SCT) for Initial Therapy of Multiple Myeloma (MM) By Patient Race: Exploring Intra-Racial Healthcare Disparities

Sikander Ailawadhi, Ryan D. Frank, Nicolette T. Chimato, Zahara Meghji, Raj Patel, MD, Prachi Jani, MD, Tanya S. Kakar, Mark A. Fiala, BS, Sonikpreet Aulakh, MD, David O. Hodge, MS, Taimur Sher, MD, Vivek Roy, MD, Prakash Vishnu, MD FACP, Meghna Ailawadhi, MD, Victoria R. Alegria, Aneel Paulus, MD, Asher A. Chanan-Khan, MD

Blood (2017) 130 (Supplement 1): 860.

https://doi.org/10.1182/blood.V130.Suppl_1.860.860

Published: 2017

Journal Articles

DA.R-EPOCH Vs. R-CHOP for High-Risk Diffuse Large B- Cell Lymphoma: The Mayo Clinic Florida Experience

Bhagirathbhai Dholaria, MBBS, Prakash Vishnu, MD FACP, Vivek Roy, MD, Han W Tun, MD, Taimur Sher, MD, Candido E. Rivera, MD, Sikander Ailawadhi, Nancy Diehl, David O. Hodge, MS, Yenni Alejandro Moreno-Vanegas

Blood (2017) 130 (Supplement 1): 1572.

https://doi.org/10.1182/blood.V130.Suppl_1.1572.1572

Published: 2017

Journal Articles

Three-Month Cumulative Incidence of Thromboembolism and Bleeding After Periprocedural Anticoagulation Management of Patients with Active Cancer.

Alfonso J Tafur, M.D., Edyta Wolny, M.D., Ph.D., Robert McBane, II, M.D., Edyta Sutkowska, Joshua P Slusser, David O Hodge, MS, John A. Heit, Waldemar E Wysokinski, M.D., Ph.D.

Blood (2009) 114 (22): 491.

https://doi.org/10.1182/blood.V114.22.491.491

Published: 2009

NARROW

Reduced Calf Muscle Pump Function Is a Risk Factor for Venous Thromboembolism and Mortality

Incidental Pulmonary Embolism. Analysis of Mayo Clinic Venous Thromboembolism Database

Treatment of Upper Extremity Deep Vein Thrombosis with Apixaban and Rivaroxaban

Cancer-Associated Thrombosis and Bleeding Risk in Gastrointestinal Malignancies with Apixaban and Rivaroxaban Compared to Low Molecular Weight Heparin

Utilization of Radiation Therapy in Multiple Myeloma: Trends and Changes in Practice

Monoclonal Antibody Utilization Characteritics in Patients with Multiple Myeloma

Safety and Efficacy of Apixaban and Rivaroxaban for the Treatment of Upper Extremity Deep Vein Thrombosis

Utilization of Palliative Care Among Patients with Hematologic Malignancies: An Extensive National Analysis to Define Trends and Patterns

Survival Trends in Young Patients with Multiple Myeloma: Focus on Racial-Ethnic Minorities

Factors Determining Utilization of Stem Cell Transplant (SCT) for Initial Therapy of Multiple Myeloma (MM) By Patient Race: Exploring Intra-Racial Healthcare Disparities

DA.R-EPOCH Vs. R-CHOP for High-Risk Diffuse Large B- Cell Lymphoma: The Mayo Clinic Florida Experience

Three-Month Cumulative Incidence of Thromboembolism and Bleeding After Periprocedural Anticoagulation Management of Patients with Active Cancer.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only